11. Bibliography – Mood & Food

Alramadhan, E., Hanna, M., Hanna, M., Goldstein, T., Avila, S. and Weeks, B. (2012). Dietary and botanical anxiolytics. Medical Science Monitor, 18(4), pp.RA40-RA48.

Amsterdam, J.D., Shults, J., Soeller, I., Mao, J.J., Rockwell, K., and Newberg, A.B. (2012). Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: An exploratory study. Alternative Therapies in Health and Medicine 18, 44–49.

Ataseven, N., Yüzbaşioğlu, D., Keskin, A.Ç., and Ünal, F. (2016). Genotoxicity of monosodium glutamate. Food and Chemical Toxicology 91, 8–18.

Beirne, A. and Nicolle, L. (2010). Biochemical imbalances in disease. London: Singing Dragon.

Bjelland, I., Tell, G., Vollset, S., Konstantinova, S. and Ueland, P. (2009). Choline in anxiety and depression: the Hordaland Health Study. The American Journal of Clinical Nutrition, 90(4), pp.1056-1060.

Bottiglieri, T. (2000). Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology, Neurosurgery & Psychiatry, 69(2), pp.228-232.

Bottiglieri, T. (2002). S-Adenosyl-l-methionine (SAMe): from the bench to the bedside—molecular basis of a pleiotrophic molecule. The American Journal of Clinical Nutrition, 76(5), pp.1151S-1157S.

Brown, R.P., Kocsis, J.H., Caroff, S., Amsterdam, J., Winokur, A., Stokes, P., and Frazer, A. (1987). Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients. Acta Psychiatrica Scandinavica 76, 272–275.

Campbell-McBride, N. (2017). Gut and psychology syndrome. [Cambridge (U.K.)]: Medinform Publishing.

Cases, J., Ibarra, A., Feuillère, N., Roller, M. and Sukkar, S. (2010). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism, 4(3), pp.211-218.

Cope, E. and Levenson, C. (2010). Role of zinc in the development and treatment of mood disorders. Current Opinion in Clinical Nutrition and Metabolic Care, 13(6), pp.685-689.

Coppen, A., and Bolander-Gouaille, C. (2005). Treatment of depression: time to consider folic acid and vitamin B12. Journal of Psychopharmacology (Oxford, England) 19, 59–65.

Derom, M.-L., Sayón-Orea, C., Martínez-Ortega, J.M., and Martínez-González, M.A. (2013). Magnesium and depression: a systematic review. Nutritional Neuroscience 16, 191–206.

Frangou, S., Lewis, M., and McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. In British Journal of Psychiatry, pp. 46–50.

Gautam, M., Agrawal, M., Gautam, M., Sharma, P., Gautam, A. and Gautam, S. (2012). Role of antioxidants in generalised anxiety disorder and depression. Indian Journal of Psychiatry, 54(3), p.244.

Gloth, F.M., Alam, W., and Hollis, B. (1999). Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. The Journal of Nutrition, Health & Aging 3, 5–7.

Gordillo-Bastidas, E., Díaz-Rizzolo, D.., Roura, E., Massanés, T., and Gomis, R. (2016). Quinoa (Chenopodium quinoa Willd), from Nutritional Value to Potential Health Benefits: An Integrative Review. Journal of Nutrition & Food Sciences 06, 1–10.

Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., and Caraci, F. (2014). Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLoS ONE 9.

Grzanna, R., Lindmark, L., and Frondoza, C.G. (2005). Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions. Journal of Medicinal Food 8, 125–132.

Harms, L.R., Burne, T.H.J., Eyles, D.W., and McGrath, J.J. (2011). Vitamin D and the brain. Best Practice and Research: Clinical Endocrinology and Metabolism 25, 657–669.

Hedaya, R. and Quinn, S. (2008). Depression. Gig Harbor, Wash.: Institute for Functional Medicine.

Held, K., Antonijevic, I., Künzel, H., Uhr, M., Wetter, T., Golly, I., Steiger, A. and Murck, H. (2002). Oral Mg2+ Supplementation Reverses Age-Related Neuroendocrine and Sleep EEG Changes in Humans. Pharmacopsychiatry, 35(4), pp.135-143.

Hoffer, A. (1998). Vitamin B-3 & schizophrenia. Kingston, Ont.: Quarry Health Books.

Kalueff, A. and Nutt, D. (2007). Role of GABA in anxiety and depression. Depression and Anxiety, 24(7), pp.495-517.

Lương, K. and Nguyễn, L. (2011). The Impact of Thiamine Treatment on Generalized Anxiety Disorder. International Journal of Clinical Medicine, 02(04), pp.439-443.

Marik, P. and Bellomo, R. (2013). Stress hyperglycemia: an essential survival response!. Critical Care, 17(2), p.305.

McCabe, D. (2016). Feed your brain. Exisle Publishing.

Michael, T. and Margraf, J. (2004). Epidemiology of anxiety disorders. Psychiatry, 3(4), pp.2-6.

Miller, A.H., and Raison, C.L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology 16, 22–34.

Miller, A.L. (2008). The methylation, neurotransmitter, and antioxidant connections between folate and depression. Alternative Medicine Review 13, 216–226.

O’Mahony, S., Clarke, G., Borre, Y., Dinan, T. and Cryan, J. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, pp.32-48.

Panossian, A. and Wikman, G. (2009). Evidence-Based Efficacy of Adaptogens in Fatigue, and Molecular Mechanisms Related to their Stress-Protective Activity. Current Clinical Pharmacology, 4(3), pp.198-219.

Parker, G., Neville Gibson, F.A., Brotchie, H., Gabriella Heruc, B., Rees, A.-M., and Dusan Hadzi-Pavlovic, D. (2006). Omega-3 Fatty Acids and Mood Disorders. Am J PsychiatryAm J Psychiatry 1636, 969–978.

Parker, S. (n.d.). The concise human body book. Dorling Kindersley Ltd.

Rogers, G., Keating, D., Young, R., Wong, M., Licinio, J. and Wesselingh, S. (2016). From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular Psychiatry, 21(6), pp.738-748.

Russo, A. (2011). Decreased Zinc and Increased Copper in Individuals with Anxiety. Nutrition and Metabolic Insights, 4, p.NMI.S6349.

Schaechter, J. and Wurtman, R. (1990). Serotonin release varies with brain tryptophan levels. Brain Research, 532(1-2), pp.203-210.

Scholey, A., Gibbs, A., Neale, C., Perry, N., Ossoukhova, A., Bilog, V., Kras, M., Scholz, C., Sass, M., and Buchwald-Werner, S. (2014). Anti-stress effects of lemon balm-containing foods. Nutrients 6, 4805–4821.

Scott, T. (2011). The anti-anxiety food solution. Oakland, CA: New Harbinger Publications.

Simopoulos, A. (2003). Importance of the Ratio of Omega-6/Omega-3 Essential Fatty Acids: Evolutionary Aspects. World Review of Nutrition and Dietetics, pp.1-22.

Stillwell, W., and Wassall, S.R. (2003). Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chemistry and Physics of Lipids 126, 1–27.

Tizaoui, K., Kaabachi, W., Hamzaoui, A., and Hamzaoui, K. (2015). Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cellular & Molecular Immunology 12, 243–252.

Unno, K., Tanida, N., Ishii, N., Yamamoto, H., Iguchi, K., Hoshino, M., Takeda, A., Ozawa, H., Ohkubo, T., Juneja, L. and Yamada, H. (2013). Anti-stress effect of theanine on students during pharmacy practice: Positive correlation among salivary α-amylase activity, trait anxiety and subjective stress. Pharmacology Biochemistry and Behavior, 111, pp.128-135.

Van Riel, E., Meijer, O., Steenbergen, P. and Joëls, M. (2003). Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience, 120(3), pp.649-658.

Yehuda, S., Rabinovitz, S. and Mostofsky, D. (2005). Mixture of essential fatty acids lowers test anxiety. Nutritional Neuroscience, 8(4), pp.265-267.

Zarrindast, M.R., and Khakpai, F. (2015). The modulatory role of dopamine in anxiety-like behavior. Archives of Iranian Medicine 18, 591–603.